Significance of Amylase Monitoring in Peritoneal Drainage Fluid after Splenectomy: A Clinical Analysis of Splenectomy in 167 Patients with Hepatolenticular Degeneration.


Journal

The American surgeon
ISSN: 1555-9823
Titre abrégé: Am Surg
Pays: United States
ID NLM: 0370522

Informations de publication

Date de publication:
01 Apr 2020
Historique:
entrez: 12 5 2020
pubmed: 12 5 2020
medline: 28 5 2020
Statut: ppublish

Résumé

Different kinds of complications after splenectomy in hepatolenticular degeneration patients with hypersplenism have been reported in the past decades, but studies on pancreatic fistula and the corresponding targeted prevention and treatment after splenectomy still remain much unexplored. The present work investigated the pathogenic factors of pancreatic fistula after splenectomy and the variation tendency of amylase in drainage fluid, aiming to verify the significance of monitoring amylase in the abdominal drainage fluid in the early diagnosis of pancreatic fistula after splenectomy. One hundred sixty-seven patients with hepatolenticular degeneration and hypersplenism who underwent splenectomy in the First Affiliated Hospital of Anhui University of Traditional Chinese Medicine from January 2016 to August 2018 were selected and analyzed. The amylase in the abdominal drainage fluid was monitored routinely after splenectomy. We also conducted the statistics on the incidence of different types of pancreatic fistula and analyzed the influence factors of pancreatic fistula formation. After splenectomy, biochemical fistula occurred in 11 patients (6.6%), grade B fistula in six patients (3.6%), grade C fistula in one patient (0.6%), and the incidence of pancreatic fistula was 4.2 per cent (biochemical fistula excluded). The amylase in the peritoneal drainage fluid was closely concerned with the incidence of pancreatic fistula according to our statistics. Furthermore, by analyzing the different influence factors of pancreatic fistula, Child-Pugh grading of liver function (

Identifiants

pubmed: 32391757

Substances chimiques

Biomarkers 0
Amylases EC 3.2.1.-

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

334-340

Auteurs

Yi Shen (Y)

From the *Department of General Surgery, The First Affiliated Hospital of Anhui University of Chinese Medicine, Hefei, China and.

Binbin Guo (B)

From the *Department of General Surgery, The First Affiliated Hospital of Anhui University of Chinese Medicine, Hefei, China and.

Laiyong Wang (L)

From the *Department of General Surgery, The First Affiliated Hospital of Anhui University of Chinese Medicine, Hefei, China and.

Hui Peng (H)

From the *Department of General Surgery, The First Affiliated Hospital of Anhui University of Chinese Medicine, Hefei, China and.

Jinfang Pan (J)

From the *Department of General Surgery, The First Affiliated Hospital of Anhui University of Chinese Medicine, Hefei, China and.

Qi Zhang (Q)

From the *Department of General Surgery, The First Affiliated Hospital of Anhui University of Chinese Medicine, Hefei, China and.

Long Huang (L)

From the *Department of General Surgery, The First Affiliated Hospital of Anhui University of Chinese Medicine, Hefei, China and.

Fuhai Zhou (F)

From the *Department of General Surgery, The First Affiliated Hospital of Anhui University of Chinese Medicine, Hefei, China and.

Qingsheng Yu (Q)

From the *Department of General Surgery, The First Affiliated Hospital of Anhui University of Chinese Medicine, Hefei, China and.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH